Spiking yields are spooking the stock market. These equities win when rates rise

The U.S. 10-year Treasury yield is at 4.59% and the 30-year yield at 5.12%, with the 30-year recently topping 5.19%, its highest since July 2007. Piper Sandler says higher rates may favor defensive names with high correlation to the 10-year yield, including Genuine Parts (78% correlation) and Conagra Brands (75% correlation), plus insurers such as Arch Capital, Cigna, and Everest. The call is a relative-value rotation note rather than a broad market catalyst.

Analysis

The market is treating higher yields as a valuation issue, but the sharper second-order effect is earnings dispersion: firms with pricing power and low refinancing needs can actually see relative momentum while long-duration growers get hit twice, through both multiple compression and higher hurdle rates. The names highlighted are effectively “rate insulation” trades, but the better frame is duration mismatch — businesses tied to maintenance, replacement, or regulated/defensive demand should hold up better than cyclical spend that depends on cheap financing.

GPC and CAG are not pure bond-proxies; they are operating leverage beneficiaries only if rate pressure is paired with softer consumer confidence. In that scenario, deferred new purchases support auto parts replacement and private-label/center-aisle food trade-down, but the upside is capped if input costs re-accelerate or if consumers absorb higher rates without cutting big-ticket purchases. The cleaner read is that these are relative-value longs, not absolute alpha machines — their best performance likely comes in a choppy, range-bound macro where defensive cash flows regain scarcity value.

For insurers, the more important effect is that rate sensitivity cuts both ways: a higher yield curve improves reinvestment income, but if the move is driven by term-premium volatility rather than growth, capital markets losses and equity drawdowns can offset the benefit. That makes the trade highest quality when elevated yields persist without credit stress; if spreads start widening, the “benefit” can vanish quickly. The key catalyst window is the next several weeks of rate moves, not a multiyear secular call — these are positioning trades around current factor leadership, not structural compounders.

Contrarianly, the consensus may be underestimating how quickly the market could rotate back to rate beneficiaries if yields stop making new highs: the same stocks that outperformed on recession fear can snap back if the 10-year stabilizes even 25-50 bps lower. Conversely, if yields keep grinding up, the biggest losers are likely not the obvious small-cap rate sensitives but the crowded mega-cap growth names whose valuations still embed perfection. That creates an asymmetric relative opportunity versus the broad index, rather than a simple absolute long basket.

Key Decisions for Investors

• Long GPC / short a basket of high-duration consumer discretionary names for 4-8 weeks; target a 2:1 upside if yields stay above recent highs, with stop-loss if the 10-year breaks back below the prior support zone.
• Long CAG on a 1-3 month horizon as a defensive trade-down beneficiary; trim into any commodity-margin squeeze, since the bull case is multiple support rather than explosive earnings growth.
• Pair trade: long selected insurers versus short long-duration growth proxies for the next FOMC/rates window; this works best if yields remain elevated but credit spreads stay contained.
• Use NVDA as a hedge against the “rates higher for longer” scenario by reducing gross exposure to the most valuation-sensitive growth exposure; the risk/reward worsens if bond yields keep rising even with strong AI fundamentals.
• If the 10-year yield reverses sharply lower, fade the rate-beneficiary basket and rotate back to quality growth; these names should be treated as tactical longs, not strategic core holdings.